Phoenix Financial recently acquired more than 3.5 million additional shares of Teva Pharmaceutical Industries in the third ...

Teva Pharmaceutical Industries reported on Wednesday a higher-than-expected rise in third-quarter profit, helped by strong ...

Teva Pharmaceutical Industries Ltd. stock rose 12% after the company reported stronger-than-expected third-quarter results, buoyed by robust growth in its branded drug portfolio. The Tel Aviv-based ...

Israel-based Phoenix Financial acquired more than 3.5 million additional shares of Teva Pharmaceuticals for an estimated $62.1 million in the third quarter. Post-transaction, the fund reported holding ...

Teva CEO Richard Francis said, "Following the conclusion of the IRA pricing negotiations, we are reiterating our strong ...

The last remaining defendants in New York’s once-sprawling opioid trial settled on Thursday. By Sarah Maslin Nir The agency cited Teva’s continuing supply problems as well as those of other drug ...

Teva Canada welcomes the recent announcement from Québec's Ministry of Health regarding changes to the reimbursement ...

Teva Pharmaceutical Industries Ltd (TEVA) reports its 11th consecutive quarter of growth, driven by innovative products, despite facing challenges in the generics market and cash flow.

Sound Shore Management, an investment management firm, has released its investor letter for the third quarter of 2023. A copy of the same can be downloaded here. In the third quarter, the Sound Shore ...

Teva Pharmaceutical Industries Ltd ADR stock has reached a new 52-week high, touching 23.07 USD. This milestone reflects a significant upward trend in the company’s stock performance over the past ...

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Thursday. A number of ...